approval · primary record
LANADELUMAB-FLYO
FDA · BLA · 2026-08-20
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-08-20 |
| Brand | TAKHZYRO |
| Sponsor | DYAX CORP. |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:29:24.089Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:LANADELUMAB-FLYO:2026-08-20
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.